Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH)

4.08
Delayed Data
As of Jul 22
 +0.03 / +0.74%
Today’s Change
3.12
Today|||52-Week Range
51.41
-59.32%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues7.6M10.5M9.1M11.7M
 
 
 
 
 
Depreciation And Amortization353.0K129.0K124.0K193.0K
 
 
 
 
 
 
Operating ExpensesGross Income7.2M------
 
 
General Expenses21.3M38.5M74.7M94.5M
 
 
 
 
 
Research And Development17.3M31.5M61.9M73.8M
 
 
 
 
 
Total Operating Expenses21.6M38.7M74.9M94.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-14.0M-28.2M-65.8M-83.0M
 
 
 
 
 
Extraordinary Charge-610.0K0.00--0.00
 
 
Interest Expense On Debt1.0M1.7M1.0M231.0K
 
 
 
 
 
Other Expenses547.0K263.0K24.0K-2.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.1M-29.6M-66.7M-83.2M
 
 
 
 
 
Net Income-15.1M-29.6M-66.7M-83.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS19.9M16.7M26.8M35.3M
 
 
 
 
 
Shares To Calculate EPS Diluted19.9M16.7M26.8M35.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.65-$1.78-$2.49-$2.36
 
 
 
 
 
EPS Diluted-$0.76-$1.78-$2.49-$2.36